Featured Stories

Filter by:

Oxford BioDynamics to Use New Technology as Partner in REFINE-ALS Biomarker Study

ALS News Today |
View Article

Queen’s Awards success for businesses backed by Innovate UK

GOV.UK |
View Article

OBD Joins Imperial in a Prostate Cancer Trial

Investis |
View Article

The high-tech hunt for new biomarkers

Medical Device Network |
View Article

Epigenetic biomarkers predict immunotherapy success

European Biotechnology |
View Article

INTERVIEW: Oxford BioDynamics Highly promising new approach ALS diagnosis

DirectorsTalk |
View Article